Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last CNY12.64 CNY
Change Today +0.60 / 4.98%
Volume 39.4M
600222 On Other Exchanges
Symbol
Exchange
Shanghai
As of 3:05 AM 05/6/15 All times are local (Market data is delayed by at least 15 minutes).

henan taloph pharmaceutica-a (600222) Snapshot

Open
CNY12.10
Previous Close
CNY12.04
Day High
CNY12.94
Day Low
CNY12.10
52 Week High
04/8/15 - CNY14.50
52 Week Low
12/23/14 - CNY6.71
Market Cap
7.3B
Average Volume 10 Days
25.3M
EPS TTM
CNY0.05
Shares Outstanding
573.9M
EX-Date
06/13/14
P/E TM
271.7x
Dividend
--
Dividend Yield
0.20%
Current Stock Chart for HENAN TALOPH PHARMACEUTICA-A (600222)

Related News

No related news articles were found.

henan taloph pharmaceutica-a (600222) Related Businessweek News

No Related Businessweek News Found

henan taloph pharmaceutica-a (600222) Details

Henan Taloph Pharmaceutical Stock Co., Ltd. develops, manufactures, and sells traditional Chinese medicines and western pharmaceuticals in China. The company primarily offers its products in the form of oral liquids, tablets, capsules, and infusions. Its products include Chinese medicinal oral solutions, such as Shuanghuanglian oral solutions for curing cold; Fluconazole injection for curing virus infection; and solid preparations, including Glipizide tablets for curing diabetes, as well as Huperzine A tablets for memory improvement and senile dementia. The company also offers bamboo amine, a phenoxybenzamine hydrochloride tablet; and mesylate pazufloxacin sodium chloride injection, as well as provides pharmaceutical raw materials. It serves hospitals, pharmacies, and patients. The company was formerly known as Henan Joyline & Joysun Pharmaceutical Stock Co., Ltd. Henan Taloph Pharmaceutical Stock Co., Ltd. is based in Zhengzhou, China.

henan taloph pharmaceutica-a (600222) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

henan taloph pharmaceutica-a (600222) Key Developments

Henan Taloph Pharmaceutical Stock Co., Ltd. Reports Earnings Results for the First Quarter of 2015

Henan Taloph Pharmaceutical Stock Co., Ltd. reported earnings results for the first quarter of 2015. For the period, the company reported basic loss per share of CNY 0.0086 and negative weighted average return on net assets of 0.46%.

Henan Taloph Pharmaceutical Stock Co., Ltd. to Report Q1, 2015 Results on Apr 25, 2015

Henan Taloph Pharmaceutical Stock Co., Ltd. announced that they will report Q1, 2015 results on Apr 25, 2015

Henan Taloph Pharmaceutical Stock Co., Ltd., Board Meeting, Apr 08, 2015

Henan Taloph Pharmaceutical Stock Co., Ltd., Board Meeting, Apr 08, 2015. Agenda: To discuss the annual report of 2014 and its abstract; to consider the scheme of profit distribution in 2014; and to consider the proposal of prediction on daily connected transactions of the company and its holding subsidiaries with related parties in 2015.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
600222:CH CNY12.64 CNY +0.60

600222 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 600222.
View Industry Companies
 

Industry Analysis

600222

Industry Average

Valuation 600222 Industry Range
Price/Earnings 100.0x
Price/Sales 6.1x
Price/Book 4.9x
Price/Cash Flow 319.5x
TEV/Sales 4.9x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact HENAN TALOPH PHARMACEUTICA-A, please visit www.taloph.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.